IL6 and COVID-19: In another study, transplantation of MSCs in COVID-19 patients was associated with a significant increase in anti-inflammatory cytokines (IL-10, IL-13) and also a significant decrease in pro-inflammatory cytokines, i.e., IFN-γ, IL-6 [62].